Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of soft tissue tumors 2020 - Secondary publication
Akira Kawai(GTx (United States)), Shintaro Iwata(National Cancer Centre Japan), Toshiyuki Kunisada(Okayama University Hospital), Kazuhiro Tanaka(Oita University), Satoshi Tsukushi(Aichi Cancer Center), Yoshihiro Nishida(Nagoya University), Norio Yamamoto, Masahiro Yoshida(International University of Health and Welfare), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Tsukasa Yonemoto, T. Akiyama, Akihiko Yoshida(Josai University), Hirotaka Kawano(University of Tokyo Hospital), Mitsuru Miyachi(Kyoto Prefectural University of Medicine), Nobuhito Araki(Mie University), Keisuke Ae, Toshifumi Ozaki(Okayama University), Norifumi Naka(University of the Witwatersrand), Shunji Takahashi(Japanese Foundation For Cancer Research)
Cited by 34
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2021|453
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343